Home / Therapeutic areas / Psychiatry
Psychiatry patient recruitment
Creating a clearer path for psychiatry recruitment requires a thoughtful approach to patient identification, engagement, and retention. Built on 20 years of learning, Clariness knows how to navigate the challenges of this therapeutic area.
The psychiatry trial landscape
3,700+
Psychiatry trials actively recruiting
4,400+
study sites seeking patients
2,800+
Clinical trial sponsors
In a market with 3,700+ clinical trials targeting a limited pool of psychiatry patients, Clariness is the right recruitment partner to ensure your study reaches the right patients ahead of your competition.
Reach & recruit the right patients, first.
Understanding the minds of patients to increase enrollment & retention
Mental health conditions affect more than 1 billion people worldwide, yet recruiting them is a screening and outreach problem, not just a disease-scale one.
- Psychiatric conditions often use patient self-identification for eligibility, but this can underdiagnose by 50% vs. clinicians
- Completion rates swing from 49% (schizophrenia) to 78% (OCD), every study needs a different strategy
- Under 10% of people with a mental health condition in low-income countries receive any care
Clariness combines 20 years of psychiatry expertise with screening, retention, and outreach strategies built for exactly these failure points.
Proven results in psychiatry recruitment
50+
Global psychiatry studies supported
20+
Years of therapeutic expertise
800+
Patients randomized globally
Major depressive
disorder
Supporting MDD clinical trials through patient-centric recruitment and tailored engagement strategies.
Post-traumatic stress disorder
Delivering patient recruitment for PTSD clinical trials with patient-centric communications that foster trust.
Attention-deficit/ hyperactivity disorder
Helping ADHD clinical trials through targeted recruitment across adolescent and adult populations.
Spotlight: Clariness generated 3,000 organic visits to ClinLife® for PTSD study
- Patient recruitment for a post-traumatic stress disorder clinical trial across 4 sites in Germany
- ClinLife® was the sole digital platform used for the online campaign
- Patients with PTSD require more education in their trial journey than other indications
Our results:
- 3,000+ organic study page visits on ClinLife®
- 300 referrals & 43 screened patients
- Delivered 65% of total study randomizations
What do our clients & patients say?
-
“The ClinLife® portal emerged as a digital supporter for pre-qualified patient referrals, driving 65% of randomizations for our study. Its performance enabled us to offer treatment to a greater number of patients with PTSD at an accelerated pace.”
Global Clinical Development & OperationsBoehringer Ingelheim -
“I really got the information I needed I would recommend you to anyone”
TroudyPatient -
“It was very easy signing up for this study I really appreciate that it was not complicated thank you”
Marvene EdwardsPatient
Psychiatry FAQs
What are the biggest recruitment challenges in psychiatry clinical trials?
Psychiatry clinical trials often rely on subjective symptom reporting, making consistent patient identification and eligibility assessment more complex. Stigma surrounding mental health, high dropout rates, and treatment non-adherence can further impact recruitment and retention. Clariness addresses these challenges through protocol-specific recruitment strategies, multi-step screening tools, patient-centric communications, and ongoing engagement to improve referral quality and retention.
Why is patient engagement so important in psychiatry clinical trials?
Many psychiatry studies require long-term participation, regular assessments, and ongoing patient commitment, making engagement essential throughout the recruitment journey. Our Creatives team develops patient-friendly communications, educational materials, and clear study journey information that build trust, set expectations, and encourage continued participation.
How many psychiatry indications does Clariness support?
Clariness has supported a wide range of psychiatry indications, including major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and attention-deficit/hyperactivity disorder (ADHD).
Why is reducing stigma important in psychiatry clinical trial recruitment?
Stigma surrounding mental health can discourage patients from seeking information about clinical trials or participating in research. Our Creatives team develops empathetic, patient-centric recruitment campaigns and education materials that foster trust, address common concerns, and encourage informed participation in psychiatry clinical trials.
How does Clariness recruit patient populations for psychiatry clinical trials?
Mental health conditions affect people across all ages, backgrounds, and communities, yet participation in clinical research can vary due to differences in awareness, access, and attitudes toward treatment. Clariness develops inclusive recruitment strategies and culturally relevant communications to help sponsors reach broader, more representative patient populations.
Related insights
-
World Mental Health Awareness Month: How to recruit for mental health trials successfully
Discover six proven strategies for successful mental health clinical trial recruitment.26 May 2026Blog post -
Efficient online recruitment of patients with depressive symptoms using social media
We evidenced that social recruitment matches traditional methods on cost, but is much faster.03 Jun 2025White paper -
PTSD case study
Learn how we’ve supported Boehringer Ingelheim with patient recruitment for a PTSD study.11 Sep 2024Case study